NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 47 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,000 | 0.0% | 17,155 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $2,000 | -50.0% | 17,155 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $4,000 | 0.0% | 17,155 | 0.0% | 0.00% | -50.0% |
Q2 2018 | $4,000 | -33.3% | 17,155 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $6,000 | 0.0% | 17,155 | 0.0% | 0.00% | +50.0% |
Q4 2017 | $6,000 | – | 17,155 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |